These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17148725)

  • 21. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
    Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
    McClung MR; Geusens P; Miller PD; Zippel H; Bensen WG; Roux C; Adami S; Fogelman I; Diamond T; Eastell R; Meunier PJ; Reginster JY;
    N Engl J Med; 2001 Feb; 344(5):333-40. PubMed ID: 11172164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture.
    Ettinger B; Stuenkel CA; Schnatz PF
    Menopause; 2013 Oct; 20(10):1092-7. PubMed ID: 24048261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density loss, osteoporosis, and fractures in HIV.
    Labarga P
    AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
    Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
    J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis.
    Marcus R; Wang O; Satterwhite J; Mitlak B
    J Bone Miner Res; 2003 Jan; 18(1):18-23. PubMed ID: 12510801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment.
    Rozenberg S; Carly B; Liebens F; Antoine C
    Maturitas; 2009 Sep; 64(1):1-3. PubMed ID: 19709824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of exercise: follow-up of a randomized trial in older women with osteopenia.
    Korpelainen R; Keinänen-Kiukaanniemi S; Nieminen P; Heikkinen J; Väänänen K; Korpelainen J
    Arch Intern Med; 2010 Sep; 170(17):1548-56. PubMed ID: 20876406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
    Hough S
    S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should a diagnosis of osteopenia trigger clinical action?
    Wehren LE
    Int J Fertil Womens Med; 2003; 48(3):117-21; discussion 137-8. PubMed ID: 12839142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
    J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with the treatment of osteoporosis in Korean postmenopausal women.
    Jeon YJ; Kim JW; Park JS
    Women Health; 2014; 54(1):48-60. PubMed ID: 24219835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Zoledronic acid; useful in osteopenia?].
    Smit DL; Zillikens MC; de Jongh RT
    Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone loss in Crohn's disease: exercise as a potential countermeasure.
    Lee N; Radford-Smith G; Taaffe DR
    Inflamm Bowel Dis; 2005 Dec; 11(12):1108-18. PubMed ID: 16306774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women.
    Pfister AK; Welch CA; John M; Emmett MK
    South Med J; 2016 Feb; 109(2):118-23. PubMed ID: 26840970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of osteopenia.
    Karaguzel G; Holick MF
    Rev Endocr Metab Disord; 2010 Dec; 11(4):237-51. PubMed ID: 21234807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopenia: a diagnostic and therapeutic challenge.
    Lems WF; Raterman HG; van den Bergh JP; Bijlsma HW; Valk NK; Zillikens MC; Geusens P
    Curr Osteoporos Rep; 2011 Sep; 9(3):167-72. PubMed ID: 21695407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.